Capula Management’s Eli Lilly LLY Stock Holding History

Capula Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Sell	1,500 -300	-17%	-$304K	0.01%	310
2025 Q4	$1.93M	Buy	1,800 +600	+50%	+$574K	0.01%	228
2025 Q3	$916K	Buy	1,200 +400	+50%	+$298K	﹤0.01%	369
2025 Q2	$624K	Sell	800 -100	-11%	-$77.7K	0.01%	211
2025 Q1	$743K	Buy	+900	New	+$749K	﹤0.01%	276
2024 Q4	–	Sell	-800	Closed	-$709K	–	495
2024 Q3	$709K	Sell	800 -600	-43%	-$539K	0.01%	209
2024 Q2	$1.27M	Buy	+1,400	New	+$1.12M	0.01%	128
2023 Q4	–	Sell	-2,300	Closed	-$1.24M	–	444
2023 Q3	$1.24M	Buy	+2,300	New	+$1.19M	0.03%	185
2023 Q2	–	Sell	-64,900	Closed	-$22.3M	–	628
2023 Q1	$22.3M	Buy	64,900 +52,900	+441%	+$17.8M	0.27%	73
2022 Q4	$4.39M	Sell	12,000 -31,400	-72%	-$11.1M	0.06%	274
2022 Q3	$14M	Buy	+43,400	New	+$13.8M	0.19%	142
2020 Q1	–	Sell	-21,700	Closed	-$2.85M	–	412
2019 Q4	$2.85M	Buy	+21,700	New	+$2.52M	0.06%	220

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capula Management's LLY Position: Q1 2026 in Review

Capula Management increased its Eli Lilly (LLY) stake by 891% in Q1 2026, buying an estimated $3.19M and bringing the position to 3,499 shares worth $3.22M. The position accounts for 0.02% of the portfolio, ranked #176.

Capula Management first reported a position in LLY in Q3 2019 and has held it in 17 quarters since. The position peaked at $78.5M in Q3 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Capula Management held 3,499 shares of Eli Lilly worth $3.22M as of Q1 2026.
Capula Management bought 3,146 Eli Lilly shares in Q1 2026, an estimated $3.19M.
Eli Lilly made up 0.02% of Capula Management's portfolio in Q1 2026, its #176 holding.
Capula Management first reported a position in Eli Lilly in Q3 2019 and has held it in 17 quarters since.
Capula Management's Eli Lilly position peaked at $78.5M in Q3 2024.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.